HU168486B - Process for weakening the corona-virus-like scour of calves and that of composition containing the weakened virus mainly vaccine - Google Patents

Process for weakening the corona-virus-like scour of calves and that of composition containing the weakened virus mainly vaccine

Info

Publication number
HU168486B
HU168486B HU73BO1469A HUBO001469A HU168486B HU 168486 B HU168486 B HU 168486B HU 73BO1469 A HU73BO1469 A HU 73BO1469A HU BO001469 A HUBO001469 A HU BO001469A HU 168486 B HU168486 B HU 168486B
Authority
HU
Hungary
Prior art keywords
virus
scour
calves
weakening
corona
Prior art date
Application number
HU73BO1469A
Other languages
English (en)
Hungarian (hu)
Inventor
Charles A Mebus
Original Assignee
Univ Nebraska
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Nebraska filed Critical Univ Nebraska
Publication of HU168486B publication Critical patent/HU168486B/hu

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • A61K39/15Reoviridae, e.g. calf diarrhea virus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • A61K39/215Coronaviridae, e.g. avian infectious bronchitis virus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525Virus
    • A61K2039/5252Virus inactivated (killed)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525Virus
    • A61K2039/5254Virus avirulent or attenuated
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/54Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541Mucosal route
    • A61K2039/542Mucosal route oral/gastrointestinal
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/55Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552Veterinary vaccine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505Inorganic adjuvants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/70Multivalent vaccine
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011Details
    • C12N2720/12011Reoviridae
    • C12N2720/12034Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011Details
    • C12N2770/20011Coronaviridae
    • C12N2770/20034Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
HU73BO1469A 1972-10-30 1973-10-30 Process for weakening the corona-virus-like scour of calves and that of composition containing the weakened virus mainly vaccine HU168486B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US30217972A 1972-10-30 1972-10-30

Publications (1)

Publication Number Publication Date
HU168486B true HU168486B (en) 1976-05-28

Family

ID=23166611

Family Applications (1)

Application Number Title Priority Date Filing Date
HU73BO1469A HU168486B (en) 1972-10-30 1973-10-30 Process for weakening the corona-virus-like scour of calves and that of composition containing the weakened virus mainly vaccine

Country Status (17)

Country Link
JP (3) JPS5817169B2 (ru)
AR (1) AR200155A1 (ru)
AU (1) AU476160B2 (ru)
BE (1) BE806568A (ru)
CA (1) CA1019675A (ru)
CH (1) CH596315A5 (ru)
DD (1) DD110517A5 (ru)
DE (1) DE2354324C2 (ru)
ES (1) ES419996A1 (ru)
FI (1) FI52740C (ru)
FR (1) FR2204405B1 (ru)
GB (1) GB1401565A (ru)
HU (1) HU168486B (ru)
IE (1) IE38423B1 (ru)
NL (1) NL7314293A (ru)
SE (1) SE419500B (ru)
ZA (1) ZA738329B (ru)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6027007U (ja) * 1983-07-30 1985-02-23 株式会社 協立双葉自動機 容器回転速度調整装置付きラベリングマシン
JPH0518338Y2 (ru) * 1985-12-27 1993-05-17
ZA872532B (en) * 1986-04-21 1987-11-25 Akzo Nv Combined vaccine
GB8818415D0 (en) * 1988-08-03 1988-09-07 Animal Health Inst Vaccine
US6291228B1 (en) 1988-08-03 2001-09-18 Vericore Limited Vaccine
JPH08786B2 (ja) * 1993-02-25 1996-01-10 株式会社微生物化学研究所 牛コロナウイルス感染症ワクチン
CN108350437B (zh) 2015-11-06 2021-10-15 旭化成医疗株式会社 高感染滴度且高纯度的细小病毒的产生方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE759425A (fr) * 1969-11-28 1971-05-25 Mebus Charles A Vaccins contre la diarrhee du veau, leur preparation et emploi
US3629413A (en) * 1970-02-04 1971-12-21 Univ Southern Illinois Polyvalent bovine vaccines and methods of making and using same

Also Published As

Publication number Publication date
AR200155A1 (es) 1974-10-24
DE2354324A1 (de) 1974-05-09
FR2204405A1 (ru) 1974-05-24
CH596315A5 (ru) 1978-03-15
FI52740C (fi) 1977-11-10
DE2354324C2 (de) 1982-06-03
FI52740B (ru) 1977-08-01
JPS57131726A (en) 1982-08-14
JPS5817169B2 (ja) 1983-04-05
ZA738329B (en) 1974-09-25
IE38423L (en) 1974-04-30
JPS5757449B2 (ru) 1982-12-04
FR2204405B1 (ru) 1977-01-28
IE38423B1 (en) 1978-03-15
ES419996A1 (es) 1976-08-01
NL7314293A (ru) 1974-05-02
SE419500B (sv) 1981-08-10
AU476160B2 (en) 1976-09-16
BE806568A (fr) 1974-04-26
AU6177473A (en) 1975-04-24
JPS5531058A (en) 1980-03-05
JPS6124370B2 (ru) 1986-06-10
CA1019675A (en) 1977-10-25
JPS4980230A (ru) 1974-08-02
DD110517A5 (ru) 1974-12-20
GB1401565A (en) 1975-07-16

Similar Documents

Publication Publication Date Title
ZA731496B (en) Methods and formulations for the treatment of obesity
ZA715391B (en) Improvements and/or modifications in multi-chamber devices for packaging of pre-dosed substances
ZA718019B (en) Process for the preparation of catalysts and/or acceptors
ZA721345B (en) Improved waste treatment system
JPS5121435B1 (en) Methods of treating elongated material
AT283597B (de) Verfahren zur Herstellung von Adriamycin und Adriamycinon
HU168486B (en) Process for weakening the corona-virus-like scour of calves and that of composition containing the weakened virus mainly vaccine
IL44143A0 (en) Method of inactivating viruses and vaccines prepared thereby
PH10556A (en) Arylidine cyclonones and process for inhibiting androgen action
ZA722866B (en) Protection of materials
IL36849A (en) Method and apparatus for the treatment of textile materials
ZA717688B (en) Equine strangles vaccine and method of preparing and using the same
EG10391A (en) Process for preparation of 21-dioxy-21-n-/n methyl/-prenisolone and its salts,used for antihoemalytic
MY7700129A (en) Pharmaceutical and veterinary compositions for the treatment of hyperlipoproteinaemia
ZA718575B (en) Substituted dioxypiperidines and process for the preparation thereof
ZA712180B (en) Aminopropionanilides and process for the preparation thereof
YU34472B (en) Process for the encymatic treatment of pulse or products made thereof
AU462834B2 (en) Pharmaceutical composition and method of treatment
YU115772A (en) Process for the preparation of delta-anilino-carboxylic esters and or nitriles
ZA714297B (en) Process for the treatment of woollen material and blends thereof
IL38213A0 (en) Ibr virus vaccine and method of preparing and using the same
KE2550A (en) Process for the bulk culture of foot and mouth disease viruses
ZA71453B (en) Pressure-sensitive copying material and process for copying
AU3775272A (en) Method of and means for increasing the effectiveness of blasting
ZA71732B (en) Process for the enrichment and purification of solutions of the newcastle disease virus